InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Discover the complete record of transactions filed by Gaston-Dreyfus Remi, 董事. Director active across 1 company, notably Bionik Laboratories Corp.. In total, 6 reports have been logged. Breakdown: 2 buys · 0 sell. Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Gaston-Dreyfus Remi is Administrateur at Bionik Laboratories Corp. on the XNAS market. He has filed 6 disclosures in total, and among the sampled recent filings, the period runs from 2021-12-13 to 2023-06-21, with the transaction nature indicated as Acquisition.